Literature DB >> 18355200

Comparison between familial and sporadic cutaneous melanoma in Valencia, Spain.

E Nagore1, R Botella-Estrada, Z Garcia-Casado, C Requena, C Serra-Guillen, B Llombart, O Sanmartin, C Guillen.   

Abstract

Some clinical, pathological and genetic features have been associated to familial melanoma, particularly multiple melanoma and earlier age at diagnosis. To compare the clinical, epidemiological and pathological differences between familial and sporadic melanoma patients in Valencia, Spain, a series of 959 patients with cutaneous melanoma were selected at a single institution. For this study the following variables were selected: age, sex, melanoma site and presence of solar lentigines on the melanoma surrounding skin, histological subtype, tumor thickness, stage, family and personal history of cutaneous melanoma and of other neoplasias, personal history of non-melanoma skin cancer, past personal history of severe sunburns, cutaneous phenotype (phototype, hair and eyes colors number of common nevus, number of atypical nevi, presence of solar lentigines). Forty-one (4.28%) familial and 918 sporadic melanoma were identified. Among the multiple variables studied, a younger age at diagnosis (median age of 42 vs 53 years), higher frequency of the presence of at least one clinically atypical nevus (36.1% vs 17.7%), multiple melanomas (12.2% vs 3.4%) and red/blonde hair (33.3% vs 18.9%), and a lower rate of cases with solar lentigines in melanoma site (33.3% vs 56.3%) were found for familial cases. Except for hair color and age, the other variables remained statistically significant after the multivariate study. Interestingly, no acral melanomas were found among the familial cases. In summary, phenotypic risk factors for familial melanoma are a tendency to develop multiple melanomas, to have clinically atypical nevi and to present less actinic damage at the melanoma site. All these results enhance the relevancy of genetic susceptibility associated to the ability to produce atypical nevi and partly to a higher sensitivity to the sun.

Entities:  

Mesh:

Year:  2008        PMID: 18355200     DOI: 10.1111/j.1468-3083.2008.02682.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  6 in total

1.  Histologic features of melanoma associated with CDKN2A genotype.

Authors:  Michael R Sargen; Peter A Kanetsky; Julia Newton-Bishop; Nicholas K Hayward; Graham J Mann; Nelleke A Gruis; Margaret A Tucker; Alisa M Goldstein; Giovanna Bianchi-Scarra; Susana Puig; David E Elder
Journal:  J Am Acad Dermatol       Date:  2015-01-13       Impact factor: 11.527

2.  Characterization of nonacral melanoma patients without typical risk factors.

Authors:  Maria M Canelas; Justo Lorenzo Bermejo; Maria Teresa Landi; Celia Requena; Carlos Guillen; Rajiv Kumar; Eduardo Nagore
Journal:  Melanoma Res       Date:  2012-08       Impact factor: 3.599

3.  Clinical and Histopathological Characteristics between Familial and Sporadic Melanoma in Barcelona, Spain.

Authors:  Paula Aguilera; Josep Malvehy; Cristina Carrera; Josep Palou; Joan Anton Puig-Butillé; Llúcia Alòs; Celia Badenas; Susana Puig
Journal:  J Clin Exp Dermatol Res       Date:  2014-09

4.  Frequency and characteristics of familial melanoma in Spain: the FAM-GEM-1 Study.

Authors:  Iván Márquez-Rodas; Manuel Martín González; Eduardo Nagore; Cristina Gómez-Fernández; Jose Antonio Avilés-Izquierdo; Cayetana Maldonado-Seral; Virtudes Soriano; Margarita Majem-Tarruella; Virginia Palomar; Rocio Maseda; Alfonso Martín-Carnicero; Teresa Puertolas; Elena Godoy; Pablo Cerezuela; Maria Ochoa de Olza; Begoña Campos; Elisabeth Perez-Ruiz; Ainara Soria; Irene Gil-Arnaiz; Maria Gonzalez-Cao; Elisa Galvez; Ana Arance; Joaquin Belon; Luis de la Cruz-Merino; Salvador Martín-Algarra
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

5.  Hereditary melanoma: a five-year study of Brazilian patients in a cancer referral center - phenotypic characteristics of probands and pathological features of primary tumors.

Authors:  Bianca Costa Soares de Sá; Luciana Facure Moredo; Elimar Elias Gomes; Erica Sara Souza de Araújo; João Pedreira Duprat
Journal:  An Bras Dermatol       Date:  2018-06       Impact factor: 1.896

6.  Management of melanoma families.

Authors:  Wilma Bergman; Nelleke A Gruis
Journal:  Cancers (Basel)       Date:  2010-04-16       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.